Catalent Inc (CTLT)
60.98
+1.32
(+2.21%)
USD |
NYSE |
Nov 22, 16:00
60.91
-0.07
(-0.11%)
After-Hours: 20:00
Catalent Free Cash Flow: 99.00M for Sept. 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2024 | 99.00M |
| June 30, 2024 | -59.00M |
| March 31, 2024 | -123.00M |
| December 31, 2023 | -263.00M |
| September 30, 2023 | -235.00M |
| June 30, 2023 | -322.00M |
| March 31, 2023 | -563.00M |
| December 31, 2022 | -371.00M |
| September 30, 2022 | -471.00M |
| June 30, 2022 | -221.00M |
| March 31, 2022 | -110.00M |
| December 31, 2021 | -183.00M |
| September 30, 2021 | -244.00M |
| June 30, 2021 | -253.00M |
| March 31, 2021 | -188.10M |
| December 31, 2020 | -134.70M |
| September 30, 2020 | 22.30M |
| June 30, 2020 | -26.00M |
| March 31, 2020 | -36.40M |
| December 31, 2019 | 20.50M |
| September 30, 2019 | -21.20M |
| June 30, 2019 | 30.00M |
| March 31, 2019 | 75.00M |
| Date | Value |
|---|---|
| December 31, 2018 | 108.10M |
| September 30, 2018 | 159.90M |
| June 30, 2018 | 198.00M |
| March 31, 2018 | 201.70M |
| December 31, 2017 | 210.90M |
| September 30, 2017 | 180.10M |
| June 30, 2017 | 159.70M |
| March 31, 2017 | 113.60M |
| December 31, 2016 | 68.60M |
| September 30, 2016 | 24.60M |
| June 30, 2016 | 15.70M |
| March 31, 2016 | 58.40M |
| December 31, 2015 | 90.70M |
| September 30, 2015 | 113.50M |
| June 30, 2015 | 30.80M |
| March 31, 2015 | 10.60M |
| December 31, 2014 | -15.60M |
| September 30, 2014 | -21.50M |
| June 30, 2014 | 55.90M |
| March 31, 2014 | 48.10M |
| December 31, 2013 | 42.90M |
| September 30, 2013 | 34.10M |
| June 30, 2013 | 15.20M |
Free Cash Flow Range, Past 5 Years
-563.00M
Minimum
Mar 2023
99.00M
Maximum
Sep 2024
-183.07M
Average
-185.55M
Median
Free Cash Flow Benchmarks
| Eli Lilly and Co | -2.275B |
| Boston Scientific Corp | 1.892B |
| Pfizer Inc | 8.227B |
| Merck & Co Inc | 14.84B |
| Avid Bioservices Inc | -11.45M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 61.00M |
| Cash from Investing (Quarterly) | -34.00M |
| Cash from Financing (Quarterly) | -10.00M |
| Free Cash Flow Per Share (Quarterly) | 0.022 |
| Free Cash Flow to Equity (Quarterly) | -25.00M |
| Free Cash Flow to Firm (Quarterly) | 70.15M |
| Free Cash Flow Yield | 0.89% |